Ives Jeffrey L.

CIK 00016140962 companiesNEWTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001614096

Recent Transactions

50 trades

Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2026-06-03+53,250→ 53,250 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-06-03+35,500→ 48,300 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2025-06-04+12,800→ 12,800 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2025-06-04+19,500→ 19,500 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2024-06-10+25,000→ 25,000 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2024-06-04+195,000→ 195,000 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2024-06-04+150,647→ 198,485 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2023-08-17−2,800→ 0 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2023-08-17$6.66/sh−2,800→ 0 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2023-08-17$0.72/sh+39,149→ 39,149 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2023-08-17$1.19/sh+2,800→ 2,800 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2023-08-17−39,149→ 0 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2023-08-17$6.48/sh−39,149→ 0 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2023-06-06+25,000→ 25,000 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2023-06-01+32,362→ 47,838 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2023-06-01+44,961→ 44,961 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2022-07-15$9.05/sh−3,600→ 15,476 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2022-06-15+25,000→ 25,000 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2022-06-02+16,996→ 16,996 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2022-06-02+11,876→ 19,076 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2021-11-12$16.04/sh−8,180→ 7,200 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (Right to Buy)
2021-06-30+34,000→ 34,000 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2021-06-07$13.05/sh−2,520→ 15,380 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2021-06-03+10,800→ 10,800 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2021-06-03+7,200→ 17,900 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-11-19$15.75/sh+2,500→ 10,700 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-11-19$15.75/sh−2,500→ 10,700 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-06-04+7,200→ 13,200 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2020-06-04+10,800→ 10,800 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2020-06-01−1,000→ 0 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-06-01$9.94/sh+1,000→ 7,000 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-06-01$16.00/sh−1,000→ 6,000 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2020-05-12−2,500→ 1,000 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-05-12$9.94/sh+2,500→ 8,500 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-05-12$16.00/sh−2,500→ 6,000 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2020-04-21−2,500→ 3,500 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-04-21$9.94/sh+2,500→ 8,500 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-04-21$16.00/sh−2,500→ 6,000 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-03-04$16.00/sh−2,500→ 6,000 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2020-03-04−2,500→ 6,000 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-03-04$9.94/sh+2,500→ 8,500 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2020-02-03−2,500→ 8,500 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-02-03$16.23/sh−2,500→ 6,000 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-02-03$9.94/sh+2,500→ 8,500 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2020-01-02−2,500→ 11,000 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-01-02$9.94/sh+2,500→ 8,500 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2020-01-02$16.13/sh−2,500→ 6,000 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2019-12-02$5.32/sh+2,500→ 8,500 total
Sale
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2019-12-02$25.83/sh−2,500→ 6,000 total
Exercise/Conversion
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2019-12-02−2,500→ 0 total

Companies

Recent Filings

Address

C/O ACUMEN PHARMACEUTICALS, INC. 1210-1220 WASHINGTON STREET, SUITE 210

NEWTON, MA, 02465

View on SEC.gov